retractable.com (RVP): Rasio utang jangka dawa marang modal

Lambang korporat lan logo Retractable Technologies Inc. (RVP)

Supply chain optimization through contract manufacturing and outsourced logistics provides Retractable Technologies (RVP) with stability. The long-term debt-to-equity ratio history confirms financial resilience, where the 0.00 mark characterizes this parameter. The VanishPoint product generates a predictable cash flow through hospital contracts, while unique patents for safety needles effectively block the expansion of low-cost generics.

retractable.com (RVP): Utang jangka dawa marang modal saka 04.07.2022 nganti 27.10.2026
Produk merek Retractable Tech

The long-term debt-to-equity ratio determines the extent of a company's reliance on borrowed funds with maturities exceeding one year. By analyzing the long-term debt-to-equity chart, an investor assesses the sustainability of financial leverage and default risks. This metric compares liabilities against equity to identify the pace of the debt load. For Retractable Technologies (RVP), a low level of borrowing is critical while stabilizing government orders for medical devices. Current retail sales support the balance sheet without excessive leveraging.

Pesaing langsung

Kewajiban jangka dawa marang modal Intuitive Surgical, Inc.|Utang jangka dawa marang modal Danaher Corp DHR|Rasio utang jangka dawa marang modal Becton Dickinson & Company (BDX)|Utang jangka dawa marang modal STE|Rasio tanggungan utang jangka dawa marang modal westpharma.com WST|BAX: Utang jangka dawa marang modal|MASI - Rasio utang jangka dawa marang ekuitas|STVN: Utang jangka dawa marang modal|TFX (Teleflex Corp) - Utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Merit Medical Systems|Utang jangka dawa marang ekuitas envistaco.com (NVST)|ICU Medical (ICUI) - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal Dentsply Sirona Inc (XRAY)|Utang jangka dawa marang modal LMAT|AtriCure Medical - Rasio tanggungan utang jangka dawa marang modal|STAAR Surgical Company (STAA) - Utang jangka dawa marang ekuitas|NAGE: Rasio utang jangka dawa marang modal|ZimVie - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka dawa marang modal AngioDynamics Inc|Cerus Corp (CERS) - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka dawa marang modal TKNO|Monogram Technologies (MGRM) - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal sharpstechnology.com STSS|Rasio utang jangka dawa marang ekuitas INFU (InfuSystem Holdings, Inc.)|Utah Medical Products Inc. - Utang jangka dawa marang modal|KRMD: Utang jangka dawa marang ekuitas|NYXH - Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang modal MBOT|PDEX (pro-dex.com) - Kewajiban jangka dawa marang modal|Utang jangka dawa marang ekuitas Zentek (ZTEK)|Rasio utang jangka dawa marang modal Elutia Inc (ELUT)|Rasio utang jangka dawa marang ekuitas Milestone Scientific Corp|Rasio silihan jangka dawa marang modal NXGL (NEXGEL Inc)|Utang jangka dawa marang ekuitas HBIO|femasys.com - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Meihua Medical (MHUA)|POAI - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal CJMB|Kewajiban jangka dawa marang modal Atrion Corporation Inc.|NeuroMetrix, Inc. (NURO) - Rasio utang jangka dawa marang ekuitas